Obesity
-
Gut microbiota metabolite protects against obesity: study
Vanderbilt researchers have discovered that beneficial bacteria in the small intestines produce a compound that protects against obesity. Read MoreDec 8, 2023
-
Vanderbilt-led team receives 2023 Endeavor Award from The Mark Foundation for Cancer Research
A multidisciplinary team of investigators has received a 2023 Endeavor Award from The Mark Foundation for Cancer Research to support four closely linked projects exploring the fundamental mechanisms that drive the obesity-cancer connection, Read MoreOct 24, 2023
-
Releasing a brake that drives obesity and diabetes
Vanderbilt researchers have uncovered a potential new way to help curb the rapidly rising worldwide prevalence of metabolic disorders, including obesity and diabetes. Read MoreSep 6, 2023
-
MicroRNAs in immune cells help protect against metabolic defects in obesity: study
Vanderbilt researchers have demonstrated that a cluster of microRNAs — small pieces of RNA that regulate gene expression — work in a type of immune cells called macrophages to help protect against metabolic defects in obesity. Read MoreSep 5, 2023
-
Watch: Lab-to-Table Conversation: ‘The Impact of Obesity on Health’
What are the scientific mechanisms by which obesity impacts the body? What are the genetic components of why some individuals struggle more with weight gain and loss? Join Professor Alyssa Hasty and panel as they explore these topics in the next Lab-to-Table Conversation from the School of Medicine Basic Sciences on Wednesday, Nov. 30, from noon to 1 p.m. CT. Read MoreNov 17, 2022
-
Weight cycling increases diabetes risk
Alyssa Hasty, Cornelius Vanderbilt Professor of Molecular Physiology and Biophysics, specializes in immunometabolism, specifically on the role that the immune system plays in obesity and metabolic disease. Recent work from her lab explored the changes in immune cell populations in fat during obesity, weight loss, and weight cycling. Read MoreJul 19, 2022
-
Study sheds light on the dark side of obesity
Vanderbilt research that promotes the anti-inflammatory pathway in macrophages could also reduce some of the bad side effects of obesity. Read MoreMay 12, 2022
-
Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics
A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes. Read MoreFeb 25, 2021
-
New treatment for a rare obesity
Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity. Read MoreNov 3, 2020
-
New tools to study bioactive lipids
Vanderbilt researchers have identified and characterized inhibitors of an enzyme that synthesizes lipid signaling molecules with roles in energy balance, inflammation and addiction. Read MoreJul 14, 2020
-
Getting the goods on obesity
Obesity and two post-operative complications linked with it have associated genetic variants in common, suggesting that obesity may be the culprit. Read MoreNov 19, 2019
-
A probiotic treatment for obesity?
Engineered bacteria that produce beneficial compounds — and that could potentially be administered in foods like yogurt — may be a future treatment for obesity and other chronic diseases. Read MoreAug 8, 2019
-
‘Helping People with Obesity Better Understand Their Surgical Options’ March 1
The Meharry-Vanderbilt Community Engaged Research Core will sponsor “Partnering to Help People with Obesity Better Understand Their Surgical Options” on Friday, March 1. The event is scheduled from 8:30 to 10 a.m. at the Metro Public Health Department, Centennial Room B, located at 2500 Charlotte Ave., Nashville. Read MoreFeb 18, 2019
-
Pilot and feasibility grants available for research related to diabetes, obesity
The Vanderbilt Diabetes Center, the Vanderbilt Diabetes Research and Training Center (DRTC), and the Vanderbilt Center for Diabetes Translation Research (CDTR) announce the availability of pilot and feasibility grants in the following areas. Read MoreNov 16, 2018
-
Clue to treating obesity found in body’s ‘rheostat’
New research by Masoud Ghamari-Langroudi and colleagues has revealed that a certain brain protein called MC3R plays a role in causing the body to reset its "ideal" weight. Read MoreAug 23, 2018
-
Study finds behavioral changes insufficient at preventing early childhood obesity
New research by Shari Barkin shows that improving nutrition and increasing opportunities to be more active were insufficient in achieving sustained reduction in childhood obesity in poor neighborhoods. Read MoreAug 9, 2018
-
Enzyme protects against obesity-related heart disease
Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction. Read MoreJun 7, 2018
-
Characterizing ‘keyhole’ is first step to fighting obesity at the cellular level
A Vanderbilt team and their international colleagues characterized for the first time a complex, little-understood cellular receptor type that, when activated, shuts off hunger. Read MoreApr 18, 2018
-
Voluntary exercise and energy balance
Non-exercise physical activity has a measurable energy expenditure, which goes down when animals engage in voluntary exercise, Vanderbilt researchers have discovered. Read MoreMar 23, 2018
-
Study explores best pre-transplant weight loss options
Vanderbilt researchers are comparing two types of weight-loss options to determine which is the most effective in helping obese patients reach a more ideal weight before undergoing kidney transplant surgery. Read MoreFeb 8, 2018